“A Phase 2 Study of Oral Difelikefalin for Moderate-to-Severe Pruritus in Subjects With Notalgia Paresthetica (KOMFORT)”. 2022. SKIN The Journal of Cutaneous Medicine 6 (6): s104. https://doi.org/10.25251/skin.6.supp.104.